TN4510 |
(+)-Medioresinol Di-O-β-D-glucopyranoside
|
88142-63-6
|
98.45%
|
|
(+)-Medioresinol Di-O-β-D-glucopyranoside has strong inhibitory activity of cyclic AMP phosphodiesterase.
|
T3987 |
Lotamilast
|
947620-48-6
|
98.44%
|
|
Lotamilast (RVT-501) is a phosphodiesterase 4 (PDE-4) inhibitor (IC50: 2.8 nM) potentially for the treatment of atopic dermatitis.
|
T23411L |
T-0156
|
324572-92-1
|
98.42%
|
|
T-0156 is a novel, potent and selective phosphodiesterase type 5 inhibitor that inhibits the hydrolysis of cyclic guanosine monophosphate (cGMP) with low affinit...
|
T38625 |
Tanimilast
|
1239278-59-1
|
98.34%
|
|
Tanimilast (CHF-6001) is a novel, potent and selective phosphodiesterase 4 inhibitor with an IC 50 value of 0.026 ± 0.006 nM.Tanimilast has potent anti-inflammat...
|
T11533 |
Z-HA155
|
1312201-00-5
|
98.28%
|
|
Z-HA155 (CS-963) selectively and potently inhibits autotaxin with an IC50 of 5.7 nM.
|
T5496 |
ML-030
|
1013750-77-0
|
98.24%
|
|
ML-030 is a potent and selective inhibitor of PDE4(PDE4A, PDE4A1, PDE4B1, PDE4B2, PDE4C1,and PDE4D2 with IC50 of 6.7 nM, 12.9 nM, 48.2 nM, 37.2 nM, 452 nM and 49...
|
T11689 |
ITI-214
|
1642303-38-5
|
98.21%
|
|
ITI-214 is a picomolar PDE1 inhibitor with excellent selectivity against other PDE family members and against a panel of enzymes, receptors, transporters, and io...
|
T61833 |
Tovinontrine
|
2062661-53-2
|
98.14%
|
|
Tovinontrine (IMR-687) (IMR-687) is a potent and selective inhibitor of phosphodiesterase-9 (PDE9), designed to target sickle cell disease treatment. It exhibits...
|
T14507 |
Bay 60-7550
|
439083-90-6
|
98.14%
|
|
Bay 60-7550 is a selective and potent PDE2 inhibitor (Ki: 3.8 nM) that exerts positive inotropic effects on rat heart by increasing PKA-mediated phosphorylation ...
|
T2923 |
Apremilast
|
608141-41-9
|
98.13%
|
|
Apremilast (CC-10004) (CC-10004) is a potent and orally active PDE4 (IC50=74 nM) with anti-inflammation activities.
|
T3465 |
Vesnarinone
|
81840-15-5
|
98.13%
|
|
Vesnarinone (Arkin) (INN) is a mixed phosphodiesterase 3 inhibitor and ion-channel modifier that has modest, dose-dependent, positive inotropic activity, but min...
|
T16379 |
Oglemilast
|
778576-62-8
|
98.11%
|
|
Oglemilast (GRC 3886) suppresses pulmonary cell infiltration, including eosinophilia and neutrophilia in vitro and in vivo. Oglemilast is an effective and orally...
|
T72031 |
BI 1015550
|
1423719-30-5
|
98.06%
|
|
BI 1015550 is an orally active inhibitor of PDE4B with an IC 50 value of 7.2 nM. BI 1015550 has good safety and potential applications in inflammation, allergic ...
|
T10545 |
BIO-32546
|
1548743-66-3
|
98.03%
|
|
BIO-32546 (S-isomer) is a highly potent regulator of autotaxin (ATX) with an IC50 value of 1 nM.
|
T1027 |
Luteolin
|
491-70-3
|
98%
|
|
Luteolin (Luteolol) belongs to the flavonoid group of natural products and is a Nrf2 inhibitor, PDE inhibitor. Luteolin has a wide range of biological activities...
|
T7346 |
Lodenafil
|
139755-85-4
|
98%
|
|
Lodenafil (Hydroxyhomosildenafil) is a potent PDE5 inhibitor, with treatment of erectile dysfunction (ED)
|
T5956 |
VP3.15 dihydrobromide
|
1281681-33-1
|
98%
|
|
VP3.15 dihydrobromide is a potent, orally bioavailable and CNS-penetrant dual phosphodiesterase (PDE7- glycogen synthase kinase (GSK)3 inhibitor(with IC50s of 1....
|
T6147 |
Nortadalafil
|
171596-36-4
|
98%
|
|
Nortadalafil (Demethyl Tadalafil) is demethyl Tadalafil, which is a PDE5 inhibitor, treating erectile dysfunction (ED) ; and under the name Adcirca for the treat...
|
T5411 |
PDE10-IN-1
|
1516896-09-5
|
98%
|
|
PDE10-IN-1 (SEP-0372814) is used for treating CNS and metabolic disorders.
|
T7642 |
Cilostamide
|
68550-75-4
|
98%
|
|
Cilostamide (OPC3689) is a selective phosphodiesterase (PDE)3A and PDE3B inhibitor(IC50 values of 27 and 50 nM, respectively)
|